SCCM Resource Library-Update on Cost and ICU Resource Utilization for Administration of Cellular Therapy: A Review of Current Data

Update on Cost and ICU Resource Utilization for Administration of Cellular Therapy: A Review of Current Data

Video Transcription

Video Summary

In this talk, the speaker gives an update on the cost and ICU utilization for cellular therapy, specifically focusing on CAR T-cell therapy. They discuss the high cost of the treatment and the concern about who will pay for it. They also highlight that the majority of costs come from facility costs during prolonged hospital stays, often in the ICU. The speaker presents data comparing CAR T patients to non-CAR T lymphoma patients admitted to the ICU, showing that CAR T patients use less high-flow oxygen, mechanical ventilation, and other interventions. They also discuss the limited interventions required for severe toxicities in CAR T patients admitted to the ICU. The talk concludes by discussing new treatments with potentially reduced toxicity and optimizing the treatment of toxicities to potentially decrease ICU admissions and costs.

Asset Subtitle

Immunology, 2023

Asset Caption

Type: one-hour concurrent | Evolving Landscape in Critical Care Medicine: Cellular Therapy-Related Toxicity (SessionID 1202444)

Meta Tag

Content Type Presentation

Knowledge Area Immunology

Membership Level Professional

Membership Level Select

Tag Immunology

Year 2023

Keywords

cellular therapy

CAR T-cell therapy

cost

ICU utilization

hospital stays

	Society of Critical Care Medicine 500 Midway Drive Mount Prospect, IL 60056 USA Phone: +1 847 827-6888 Fax: +1 847 439-7226 Email: support@sccm.org	Contact Us About SCCM Newsroom Advertising & Sponsorship DONATE	MySCCM LearnICU Patients & Families Surviving Sepsis Campaign Critical Care Societies Collaborative	GET OUR NEWSLETTER
© Society of Critical Care Medicine. All rights reserved. \| Privacy Statement \| Terms & Conditions The Society of Critical Care Medicine, SCCM, and Critical Care Congress are registered trademarks of the Society of Critical Care Medicine.